Menu

Bioethicist and Law Professor Dies

John Robertson was known for his contributions to reproductive medicine ethics and for solidifying the scholarly connection between biomedicine and law.

Jul 6, 2017
Kerry Grens

CHRISTINA MURREYJohn Robertson, a bioethicist at the University of Texas School of Law, passed away yesterday (July 5) at age 74. His work focused on reproductive technologies, and he served as chair of the ethics committee of the American Society for Reproductive Medicine.

I. Glenn Cohen, a Harvard Law professor, writes in a memorial that Robertson helped to put law and bioethics “on to the law school map, and with a few others . . . gave it legitimacy as a real and important area of focus within law schools.”

“John was one of the earliest law professors to consider medicine from an ethical and policy perspective,” Rebecca Dresser, a bioethicist and law professor at Washington University in St. Louis, said in a 2010 press release. That year, Robertson was honored with a lifetime achievement award by the American Society for Law, Medicine, & Ethics. “He showed the rest of us how it could be done, and done well.”

Robertson earned his undergraduate degree at Dartmouth College and later studied law at Harvard Law School. After nearly a decade on the faculty at the University of Wisconsin, Robertson moved to the University of Texas School of Law in 1980 and remained there until his death.

He authored several books, notably, 1994’s Children of Choice: Freedom and the New Reproductive Technologies, in which he examined interventions such as in vitro fertilization, genetic screening, and the “morning after pill.” A review of the book in the New England Journal of Medicine called it “indispensible” for anyone involved in making reproductive decisions.

“He was a man of many parts, and an uncommonly modest and warm guy,” fellow UT Law Professor Willy Forbath tells the Austin American-Stateman. “There are not many people at the law school who had such ranging friendships all across the campus.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.